- Anguilla
- Antigua
- Argentina
- Aruba, Bonaire, Curacao and St. Maarten
- Bahamas
- Belize
- Bolivia
- Brazil
- British Virgin Islands
- Canada LLP
- Canada RCGT
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Haiti
- Honduras
- Jamaica
- Mexico
- Montserrat
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- St Kitts
- St Lucia
- St Vincent and the Grenadines
- Trinidad & Tobago
- United States
- Uruguay
- Venezuela
- Albania
- Armenia
- Austria
- Azerbaijan
- Belarus
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Channel Islands
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Georgia
- Germany
- Gibraltar
- Greece
- Hungary
- Iceland
- Ireland
- Isle of Man
- Israel
- Italy - Bernoni
- Italy - Ria
- Kazakhstan
- Kosovo
- Kyrgyzstan
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- Russia
- Serbia
- Slovak Republic
- Slovenia
- Spain
- Sweden
- Switzerland
- Tajikistan
- Turkey
- Ukraine
- UK
- Uzbekistan
Biotechnology Industry Position Survey 2015
Respondents to the fifth annual AusBiotech survey were the most positive they have been regarding how their companies performed with 69% reporting a good or excellent year. The positivity extended to the industry outlook for the coming year with 84% of respondents expecting their business to grow. Concern was voiced regarding government tampering with the much loved R&D Tax Incentive, with some respondents commenting on the unsupportive environment they are operating in.
Key findings:
- Sentiment strong despite business environment
- Improved policy is all about tax reform
- Cash is the life blood of the industry
- A tough and unsupportive environment
Also appears under...